Jazz Pharmaceuticals plc JAZZ Balance Sheet

Jazz pharmaceuticals plc (JAZZ)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Dec'10
Assets [Abstract]
Current assets:
Cash and cash equivalents
701	637	795	637	547	309	499	485	453	386	252	239	346	365	366	867	979	988	998	921	782	684	575	268	245	636	588	504	450	387	189	154	170	82	101	102	44
Investments
280	440	275	245	285	515	565	330	255	215	200	80	60	60	59	48	0	0	-	-	-	-	-	-	5	-	-	-	-	-	-	-	-	-	-	-	-
Marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	73	75	12	-	-
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Accounts receivable, net of allowances
317	355	267	311	320	263	279	278	281	224	258	238	243	234	238	231	223	209	195	193	189	186	187	160	154	124	113	114	93	75	88	78	56	34	31	24	22
Inventories
85	78	71	68	60	52	43	46	46	43	41	39	37	34	32	33	25	19	30	30	30	30	37	33	36	28	24	28	22	26	30	48	16	3	4	4	5
Prepaid expenses
38	39	30	31	28	25	23	33	27	23	29	28	38	24	23	23	18	20	21	26	27	12	24	28	14	7	19	21	11	7	7	5	5	1	2	3	1
Deferred tax assets, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50	50	50	48	35	35	35	33	45	46	47	35	-	-	-	0	-	-	-
Other current assets
94	78	81	75	62	67	54	55	62	76	49	36	27	29	24	26	22	19	18	21	21	21	18	18	23	33	18	19	21	19	9	13	4	1	0	0	0
Assets held for sale
-	-	-	-	-	-	-	78	-	-	-	-	-	-	-	-	-	-	0	0	0	32	-	-	-	0	-	-	-	-	59	-	-	-	-	-	-
Total current assets
1,517	1,630	1,520	1,370	1,305	1,234	1,464	1,306	1,126	968	830	662	752	748	744	1,230	1,270	1,257	1,314	1,244	1,102	1,015	878	544	517	864	810	734	647	551	385	300	327	199	152	136	74
Property, plant and equipment, net
129	131	129	127	113	200	198	188	178	170	159	136	119	107	99	93	86	85	83	80	71	58	44	38	30	14	12	10	7	7	6	4	2	1	0	0	0
Operating lease assets
135	139	141	144	147	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible assets, net
2,238	2,440	2,593	2,687	2,679	2,731	2,787	2,842	2,953	2,979	3,019	3,033	2,998	3,012	3,110	1,300	1,348	1,185	1,270	1,282	1,284	1,437	1,550	1,680	1,755	812	823	822	835	869	876	927	326	14	16	18	22
Goodwill
909	920	906	924	919	927	932	936	960	947	941	926	899	893	927	661	670	657	669	664	654	702	724	760	763	450	446	439	436	442	437	446	239	38	38	38	38
Deferred tax assets, net
230	221	183	184	65	57	37	40	38	34	23	20	18	15	0	117	122	130	76	73	74	75	101	96	94	74	70	65	62	74	-	-	-	0	-	-	-
Deferred financing costs
6	7	7	8	9	9	10	10	7	7	8	8	9	9	10	6	6	7	24	25	31	33	35	24	25	14	15	16	15	16	-	-	-	0	-	-	-
Other non-current assets
47	47	44	40	40	42	56	23	22	16	16	16	17	14	37	37	29	9	25	22	19	15	13	11	9	7	6	5	4	3	20	19	0	0	0	0	0
Total assets
5,215	5,538	5,527	5,488	5,280	5,203	5,485	5,348	5,287	5,123	4,999	4,804	4,815	4,800	4,930	3,448	3,534	3,332	3,464	3,393	3,237	3,338	3,347	3,155	3,196	2,238	2,185	2,093	2,009	1,966	1,726	1,697	895	253	207	193	135
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
66	47	70	82	42	40	37	31	46	24	29	28	29	22	17	28	32	21	29	26	27	25	29	32	72	21	22	20	31	15	20	34	13	5	8	4	3
Accrued liabilities
261	267	238	218	292	264	257	258	240	198	179	169	183	193	172	157	307	164	166	146	146	164	161	142	147	119	106	96	100	104	123	125	74	34	35	26	23
Current portion of long-term debt
33	33	33	33	33	33	33	33	45	40	36	36	136	36	36	37	37	37	117	28	9	9	9	9	9	5	5	5	32	29	26	23	-	0	-	32	16
Income taxes payable
31	10	43	30	40	1	7	17	36	21	13	7	35	4	5	1	19	1	16	13	26	7	15	5	0	0	19	17	37	39	-	-	-	0	-	-	-
Deferred revenue
4	4	4	4	4	5	5	6	6	8	8	8	8	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	2	1	1	1	1	1
Contingent consideration
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	50	47	-	39	0	-	-	-	-	-	-	-
Deferred tax liability, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9	9	9	9	6	6	6	6	0	0	0	0	-	-	-	0	-	-	-
Purchased product rights liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	6	15	4	4	4	4
Liability under government settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	7	7	7	4
Revolving credit facility
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	7
Total current liabilities
396	364	390	369	413	345	341	347	375	293	268	250	392	257	232	226	398	226	340	225	220	216	223	197	238	204	203	184	243	191	178	192	104	52	57	81	59
Deferred revenue, non-current
4	4	6	7	8	9	10	12	13	16	18	20	22	2	2	3	3	3	3	3	4	4	4	5	5	5	6	6	6	6	7	7	7	7	8	8	9
Purchased product rights liability, non-current
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2	4
Liability under government settlement, non-current
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	6
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Long-term debt, less current portion
1,576	1,573	1,570	1,567	1,565	1,563	1,560	1,558	1,537	1,540	1,543	1,635	1,739	1,993	2,147	1,141	1,146	1,150	1,172	1,337	1,334	1,333	1,331	1,186	1,189	544	545	546	418	427	435	444	-	0	-	0	24
Operating lease liabilities, less current portion
147	151	153	156	154	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax liabilities, net
165	224	250	283	296	309	337	354	382	383	540	551	548	556	725	289	299	283	325	326	327	375	413	456	471	168	170	167	169	178	180	185	-	0	-	-	-
Contingent consideration, non-current
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	42	0	34	36	35	-	0	-	-	-
Other non-current liabilities
117	109	102	120	111	218	208	205	192	176	158	144	128	112	106	94	79	69	59	52	45	38	33	29	25	20	16	13	9	6	2	1	1	0	-	-	-
Commitments and contingencies (Note 11)
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Shareholders’ equity:
Preferred stock, $0.0001 par value per share; zero and 20,000 shares authorized; no shares issued and outstanding at December 31, 2012 and 2011, respectively
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0
Ordinary shares
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non-voting euro deferred shares
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital redemption reserve
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Additional paid-in capital
2,294	2,266	2,209	2,171	2,130	2,113	2,078	2,037	1,955	1,935	1,899	1,720	1,681	1,665	1,635	1,617	1,586	1,562	1,534	1,512	1,488	1,458	1,431	1,273	1,251	1,220	1,201	1,184	1,168	1,151	1,133	1,126	1,103	542	528	521	505
Accumulated other comprehensive loss
-257	-223	-259	-210	-220	-197	-179	-168	-98	-140	-158	-210	-299	-317	-235	-249	-222	-267	-231	-248	-278	-122	-57	59	70	56	44	19	10	31	13	-0	0	-0	-0	-	-
Retained earnings
770	1,067	1,104	1,021	819	841	1,128	1,000	929	917	728	690	601	528	315	324	242	302	260	181	95	34	-34	-53	-74	18	-2	-29	-17	-61	-261	-295	-322	-349	-387	-419	-474
Stockholders' Equity Attributable to Parent
2,808	3,110	3,054	2,983	2,730	2,757	3,027	2,869	2,786	2,713	2,469	2,201	1,983	1,877	-	-	-	-	1,563	1,446	1,305	1,371	1,340	1,279	1,248	1,295	1,243	1,175	1,161	1,121	886	831	781	192	141	101	30
Noncontrolling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	17	0	-	-	-	-	-	-	-	-	-	-	-
Total shareholders equity
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,716	1,692	1,607	1,598	1,563	1,446	1,305	1,371	1,340	1,280	1,266	1,295	-	-	-	-	-	-	-	-	-	-	-
Total liabilities and shareholders’ equity
5,215	5,538	5,527	5,488	5,280	5,203	5,485	5,348	5,287	5,123	4,999	4,804	4,815	4,800	4,930	3,448	3,534	3,332	3,464	3,393	3,237	3,338	3,347	3,155	3,196	2,238	2,185	2,093	2,009	1,966	1,726	1,697	895	253	207	193	135